Business Context and Reporting Period
This Form 8-K reports the results of the reconvened 2023 Annual Meeting of Stockholders for Kartoon Studios, Inc. (trading symbol: TOON), held on September 20, 2023. The meeting was adjourned from August 25, 2023, to allow additional time for stockholder consideration and proxy submission.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and voting results. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
The filing details the final vote counts for five proposals presented at the reconvened Annual Meeting:
- Election of Directors: All nine director nominees were elected. Significant broker non-votes (7,805,662) were recorded for each nominee, though "For" votes exceeded "Withheld" votes in all cases.
- Ratification of Auditors: The appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was approved (17,426,309 For vs. 1,953,688 Against).
- Executive Compensation (Say-on-Pay): The non-binding advisory proposal to approve named executive officer compensation was approved (8,149,341 For vs. 4,078,661 Against).
- Frequency of Say-on-Pay Votes: Stockholders approved holding future advisory votes on executive compensation every three years (6,279,925 votes for three years).
- Warrant Exercise Approval: The proposal to approve the issuance of more than 19.99% of outstanding Common Stock upon the exercise of certain warrants was approved (7,806,843 For vs. 4,558,580 Against).
Guidance, Outlook, and Risks
This filing does not contain management commentary, financial guidance, outlook, or specific risk factors. The primary operational implication is the authorization to issue significant equity upon the exercise of existing warrants, which may impact share count and dilution.
Investor Verification Checklist
- Verify the total number of shares outstanding to assess the dilution impact of the approved warrant exercise proposal.
- Review the definitive proxy statement (Schedule 14A) filed on July 14, 2023, and the supplement filed on September 12, 2023, for detailed background on the director nominees and warrant terms.
- Monitor future filings for the actual exercise of warrants and the resulting issuance of new shares.
- Check subsequent 10-Q or 10-K filings for the financial performance data not included in this 8-K.